Understanding the Kappa Opioid Receptor in a Brain Region Linked to Stress and Addiction
Kappa Opioid Receptor in Paraventricular Nucleus of Thalamus
This research explores a specific brain receptor to understand its role in stress, anxiety, and addiction, hoping to find new ways to help people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11121096 on NIH RePORTER |
What this research studies
Our brains have special receptors called kappa opioid receptors (KORs) that play a part in how we feel pain, anxiety, and even addiction. While some medicines that activate these receptors can help with pain, they often cause unpleasant side effects. This project looks at a different approach: blocking these receptors, which has shown promise in reducing anxiety and depression in animal models and might help with drug addiction in people. We are focusing on a specific brain area called the paraventricular nucleus of the thalamus (PVT), which is involved in stress and emotions, to learn more about how KORs work there. By understanding these connections, we hope to uncover new targets for treatments that could improve mental well-being and combat addiction without the unwanted side effects.
Who could benefit from this research
Good fit: Patients struggling with drug addiction, anxiety, or depression might eventually benefit from treatments developed based on this fundamental understanding of brain function.
Not a fit: Patients seeking immediate treatment options will not directly benefit from this basic science research, as it is foundational and not a clinical trial.
Why it matters
Potential benefit: If successful, this work could lead to new medications that effectively treat drug addiction, anxiety, and depression with fewer side effects than current options.
How similar studies have performed: While KOR antagonists have shown promise in animal models for antidepressant and anti-anxiety effects, this specific investigation into KOR in the PVT is a novel and foundational approach.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Liu-Chen, Lee-Yuan — Temple Univ of the Commonwealth
- Study coordinator: Liu-Chen, Lee-Yuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.